Johnson & Johnson (J&J) seeks permission for phase-3 trial of its single-shot COVID-19 vaccine, grant of import licence in India: Sources.
- Country:
- India
Johnson & Johnson (J&J) seeks permission for phase-3 trial of its single-shot COVID-19 vaccine, grant of import licence in India: Sources.
ALSO READ
-
Japanese Lawmakers Visit India to See Worker Protection and Skills Projects in Action
-
Indian Unions Push for Fair Recruitment and Rights for Care Workers in Germany
-
Cleaner Kitchens, Polluted Skies: Hidden Health Cost of India’s Electricity Boom
-
Japan-Backed ILO Projects Help 23,000 Workers Gain Rights and Fight Child Labour
-
India's Delicate Balancing Act: Navigating Energy Security Amid Middle Eastern Tensions
Google News